Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Total Current Liabilities (2022 - 2024)

Adial Pharmaceuticals' Total Current Liabilities history spans 3 years, with the latest figure at $537303.0 for Q3 2024.

  • For Q3 2024, Total Current Liabilities fell 33.94% year-over-year to $537303.0; the TTM value through Sep 2024 reached $537303.0, down 33.94%, while the annual FY2023 figure was $653076.0, 63.53% down from the prior year.
  • Total Current Liabilities for Q3 2024 was $537303.0 at Adial Pharmaceuticals, up from $322173.0 in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $2.2 million in Q1 2022 and bottomed at $322173.0 in Q2 2024.
  • The 3-year median for Total Current Liabilities is $813371.0 (2023), against an average of $1.1 million.
  • The largest YoY upside for Total Current Liabilities was 17.19% in 2023 against a maximum downside of 75.27% in 2023.
  • A 3-year view of Total Current Liabilities shows it stood at $1.8 million in 2022, then crashed by 63.53% to $653076.0 in 2023, then fell by 17.73% to $537303.0 in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Total Current Liabilities are $537303.0 (Q3 2024), $322173.0 (Q2 2024), and $595203.0 (Q1 2024).